People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Biotechnology, Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AsclepiX Therapeutics, Inc. | — | Biotechnology | Series A | $28.0M | $83.5M | 2023 |
| TherOptix, Inc. | — | Other | Series A | $5.5M | $83.2M | 2019 |
| Forwardvue Pharma, Inc. | — | Pharmaceuticals | Seed | $5.0M | $11.3M | 2020 |
Amir Shojaei at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Amir Shojaei on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Lindstrom | 1 | 13 |
| Chris Garabedian | 1 | 8 |
| Tyler Stowater | 1 | 7 |
| BARRY BUTLER | 1 | 6 |
| Adrienne Graves | 1 | 6 |
| Steven Altschuler | 1 | 5 |
| Garrett Vygantas | 1 | 4 |
| Michael Aceti | 1 | 4 |
| Ben Askew | 1 | 3 |
| Sapna Srivastava | 1 | 3 |
| Monty Montoya | 1 | 2 |
| Robert Dempsey | 1 | 2 |
| Joshua Barer | 1 | 2 |
| Jordan Green | 1 | 2 |
| Jordan J. Green | 1 | 2 |
| NEIL DONNENFELD | 1 | 1 |
| ALAN FRANKLIN | 1 | 1 |
| RAJ MATURI | 1 | 1 |
| RUBEN TIMMONS | 1 | 1 |
| BOB KATZ | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.